Christopher D. Verrico, PhD

JCP
Article

May 25, 2016

One alpha-1 noradrenergic antagonist drug has shown promise in treating PTSD-related sleep disturbances and nightmares, but it has a short half-life. Could the long half-life version of this type...
Christopher Rodgman, Christopher D. Verrico, Manuela Holst, et al
PCC
Letter to the Editor

August 15, 2014

Christopher J. C. Rodgman, Christopher D. Verrico, Ray B. Worthy, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe